lobbying_activities: 1107123
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1107123 | d1a2226a-a829-4a81-954c-f4b11a5e4172 | Q2 | CHAMBER HILL STRATEGIES | 400645947 | BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC. | 2011 | second_quarter | MMM | Implementation issues affecting biopharmaceutical manufacturers related to P.L. 111-148, the Patient Protection and Affordable Care Act, and P.L. 111-152, the Health Care and Education Reconciliation Act of 2010 | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-01T15:06:14.330000-04:00 |